(Q44650460)
Statements
A pilot study of low-dose subcutaneous alemtuzumab therapy for patients with hemotherapy-refractory chronic lymphocytic leukemia (English)
Maria Cristina Pasquini
Barbara Sarina
Giambattista Bertani
Federica Grifoni
Giorgio Lambertenghi Deliliers